|
FY2025
12 months to Jan 2, 2026
|
FY2024
12 months to Jan 3, 2025
|
FY2023
12 months to Dec 29, 2023
|
FY2022
12 months to Dec 30, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenues | |||||
| Net product revenues | |||||
| License revenues | |||||
| Collaboration services revenues | |||||
| Collaboration services revenues | |||||
| Total revenues | |||||
| Operating expenses: | |||||
| Cost of goods sold | |||||
| Research and development | |||||
| Selling, general and administrative | |||||
| Impairment of long-lived assets | |||||
| Restructuring | |||||
| Total operating expenses | |||||
| Income from operations | |||||
| Interest income | |||||
| Other income (expenses), net | |||||
| Income before income taxes | |||||
| Provision for income taxes | |||||
| Net income | |||||
| Net income | |||||
| Basic (in dollars per share) | |||||
| Diluted (in dollars per share) | |||||
| Weighted-average common shares outstanding: | |||||
| Basic (in shares) | |||||
| Diluted (in shares) |
Loading...